2022 Homecare In-home health Medicare 
Hospice News
MAY 10, 2023
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.
Hospice News
SEPTEMBER 19, 2022
Deal volume for non-medical home care companies outstripped that for hospice or home health during the first half of the year. As of the end of Q2, this included 23 deals compared to 17 each for Medicare-certified home health and for hospice, according to a report by M&A advisory firm Mertz Taggart.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
NOVEMBER 1, 2022
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
Hospice News
AUGUST 29, 2022
Disruption in home health reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. This started to level off late last year and in early 2022. Companies like LHC Group (NASDAQ: LHCG), Amedisys Inc.
Hospice News
DECEMBER 12, 2022
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. The agreement marked not only one of the largest deals in hospice, but also signaled increasing interest among payers to operate health care provider companies.
Expert insights. Personalized for you.
218 
Let's personalize your content